Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 1:05 PM UTC
| NCT Number | NCT07673016 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 2,500 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Convergent Genomics, Inc. |
| Last Updated on CT.gov | June 29, 2026 (Jun 29, 2026) |
As of August 27, 2026: Clinical trial NCT07673016 is currently recruiting participants. This clinical trial study for bladder cancer is actively seeking new participants at 21 locations across the United States. The study is sponsored by Convergent Genomics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07673016 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07673016 was last updated Jun 29, 2026 (June 29, 2026). HelloStudys verifies this status automatically.